VA Med NWI Endocrine Studies R151 — Omaha, Nebraska

VA Med NWI Endocrine Studies R151 is a clinical research site located in Omaha, Nebraska, United States 68105.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

VA Med NWI Endocrine Studies R151 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for VA Med NWI Endocrine Studies R151?

VA Med NWI Endocrine Studies R151 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has VA Med NWI Endocrine Studies R151 conducted?

VA Med NWI Endocrine Studies R151 has 1 clinical trials on record, with 1 currently active. Their work covers Atherosclerotic Cardiovascular Disease.

Is VA Med NWI Endocrine Studies R151 accredited by Crixeo Health?

VA Med NWI Endocrine Studies R151 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about VA Med NWI Endocrine Studies R151?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.